• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺头部腺癌的静脉切除术:门静脉切除范围是否影响预后?

Venous resection for adenocarcinoma of head of pancreas: Does extent of portal vein resection affect outcomes?

机构信息

Department of Gastrointestinal & HPB Surgery, Fortis Hospital, Malviya Nagar, Jaipur, 302017, India.

Department of Gastrointestinal & HPB Surgery, Fortis Hospital, Malviya Nagar, Jaipur, 302017, India.

出版信息

Surgeon. 2020 Jun;18(3):129-136. doi: 10.1016/j.surge.2019.07.004. Epub 2019 Aug 20.

DOI:10.1016/j.surge.2019.07.004
PMID:31444075
Abstract

BACKGROUND

Venous resection with pancreaticoduodenectomy (PD) increases resectability rates in patients with adenocarcinoma of head of pancreas. The effect of extent of portal vein resection on perioperative morbidity and mortality is less clear. This retrospective cohort study compares results of PD with and without venous resection and explores the influence of extent of vein resection on perioperative morbidity and mortality.

METHODS

Total 96 patients underwent standard PD (PD) and 20 patients had en bloc venous resections (VR). VR group was divided into segmental (VR-S) (6/20 patients) and tangential (VR-T) (14/20 patients) groups based on segmental or tangential type of venous resections. The groups were compared for morbidity, mortality and survival.

RESULTS

PD and VR groups had comparable perioperative morbidity (p = 0.140) and mortality (p = 0.358) with a significantly higher operative time in VR (p < 0.001). Perioperative morbidity and mortality were similar in VR-S and VR-T groups (p = 0.690 and p = 0.157 respectively). Operative time and estimated blood loss were significantly higher in VR-S group over VR-T (p = 0.019 and p = 0.002 respectively). Median survival was similar for PD and VR (15 and 15.5 moths respectively; p = 0.278) and VR-S and VR-T groups (17 and 12.5 months respectively; p = 0.550). Expected blood loss and operative time were found to be independent predictors of morbidity.

CONCLUSIONS

Venous resection with PD is associated with morbidity, mortality and overall survival comparable to that after standard resection. The extent of venous resection does not seem to affect perioperative morbidity and mortality.

摘要

背景

静脉切除术联合胰十二指肠切除术(PD)可提高胰头腺癌患者的可切除性。但门静脉切除范围对围手术期发病率和死亡率的影响尚不清楚。本回顾性队列研究比较了 PD 联合和不联合静脉切除术的结果,并探讨了静脉切除范围对围手术期发病率和死亡率的影响。

方法

共有 96 例患者接受了标准 PD(PD)治疗,20 例患者进行了整块静脉切除术(VR)。根据静脉切除的节段性或切线性,将 VR 组分为节段性(VR-S)(6/20 例)和切线性(VR-T)(14/20 例)两组。比较两组患者的发病率、死亡率和生存率。

结果

PD 组和 VR 组的围手术期发病率(p=0.140)和死亡率(p=0.358)相当,VR 组的手术时间明显更长(p<0.001)。VR-S 组和 VR-T 组的围手术期发病率和死亡率相似(p=0.690 和 p=0.157)。VR-S 组的手术时间和估计出血量明显高于 VR-T 组(p=0.019 和 p=0.002)。PD 组和 VR 组的中位生存时间相似(分别为 15 个月和 15.5 个月;p=0.278),VR-S 组和 VR-T 组的中位生存时间相似(分别为 17 个月和 12.5 个月;p=0.550)。预计出血量和手术时间是发病率的独立预测因素。

结论

PD 联合静脉切除术与标准切除术相比,其发病率、死亡率和总体生存率相当。静脉切除范围似乎不会影响围手术期发病率和死亡率。

相似文献

1
Venous resection for adenocarcinoma of head of pancreas: Does extent of portal vein resection affect outcomes?胰腺头部腺癌的静脉切除术:门静脉切除范围是否影响预后?
Surgeon. 2020 Jun;18(3):129-136. doi: 10.1016/j.surge.2019.07.004. Epub 2019 Aug 20.
2
Pancreaticoduodenectomy with vascular resection: margin status and survival duration.血管切除的胰十二指肠切除术:切缘状态与生存时长
J Gastrointest Surg. 2004 Dec;8(8):935-49; discussion 949-50. doi: 10.1016/j.gassur.2004.09.046.
3
Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.胰十二指肠切除术后门静脉/肠系膜上静脉节段性切除并采用髂静脉重建
J Int Med Res. 2016 Dec;44(6):1339-1348. doi: 10.1177/0300060516665708. Epub 2016 Nov 10.
4
Inferior mesenteric vein serves as an alternative guide for transection of the pancreatic body during pancreaticoduodenectomy with concomitant vascular resection: a comparative study evaluating perioperative outcomes.肠系膜下静脉可作为胰十二指肠切除术合并血管切除时胰体横断的替代引导:一项评估围手术期结局的对比研究。
Eur J Med Res. 2014 Aug 21;19(1):42. doi: 10.1186/s40001-014-0042-z.
5
Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy.在胰十二指肠切除术期间,可以避免进行肠系膜门静脉切除吻合术。
J Am Coll Surg. 2012 Oct;215(4):569-79. doi: 10.1016/j.jamcollsurg.2012.05.034. Epub 2012 Jul 3.
6
Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.伴有静脉受累的胰腺腺癌: upfront同步门静脉-肠系膜上静脉切除仍合理吗?法国外科协会的一项调查
Ann Surg Oncol. 2015;22(6):1874-83. doi: 10.1245/s10434-014-4304-3. Epub 2015 Feb 10.
7
Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.门静脉侵犯及侵犯范围在接受胰十二指肠切除术的胰腺腺癌患者中的意义
J Gastrointest Surg. 2016 Mar;20(3):479-87; discussion 487. doi: 10.1007/s11605-015-3005-y. Epub 2016 Jan 14.
8
Venous thrombosis following pancreaticoduodenectomy with venous resection.胰十二指肠切除术联合静脉切除术后的静脉血栓形成
J Surg Res. 2018 Aug;228:271-280. doi: 10.1016/j.jss.2018.02.006. Epub 2018 Apr 13.
9
Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.与肠系膜门静脉切除相关的不良肿瘤生物学特性影响胰腺导管腺癌患者的生存。
Ann Surg Oncol. 2014 Jun;21(6):1937-47. doi: 10.1245/s10434-014-3554-4. Epub 2014 Feb 21.
10
Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.门静脉切除在边界可切除胰腺癌中的应用:英国多中心研究。
J Am Coll Surg. 2014 Mar;218(3):401-11. doi: 10.1016/j.jamcollsurg.2013.11.017. Epub 2013 Nov 27.

引用本文的文献

1
Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whipple's (RAW) Study.胰十二指肠切除术治疗胰腺导管腺癌时的静脉切除——Whipple术后复发(RAW)研究的多中心倾向评分匹配分析
Cancers (Basel). 2025 Apr 4;17(7):1223. doi: 10.3390/cancers17071223.
2
Comparison of laparoscopic versus open pancreaticoduodenectomy combined with portal vein/superior mesenteric vein resection and reconstruction for pancreatic cancer: a propensity score matching analysis.腹腔镜与开放胰十二指肠切除术联合门静脉/肠系膜上静脉切除重建治疗胰腺癌的比较:倾向评分匹配分析
Gland Surg. 2024 May 30;13(5):607-618. doi: 10.21037/gs-23-538. Epub 2024 May 27.
3
Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy.
新辅助治疗时代的可切除边缘胰腺癌与血管切除术
World J Clin Cases. 2021 Jul 16;9(20):5398-5407. doi: 10.12998/wjcc.v9.i20.5398.
4
What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?胰头十二指肠切除术治疗胰管腺癌伴静脉受侵时应如何指导静脉切除?
Ann Surg Oncol. 2021 Oct;28(11):6211-6222. doi: 10.1245/s10434-020-09568-2. Epub 2021 Jan 21.